S.Africa in $208 mln AIDS drug venture with Swiss Lonza
South Africa on Friday unveiled plans for a 1.6 billion rand ($208 million, 157 million euro) pharmaceutical plant, in a joint venture with Swiss biochemicals group Lonza to produce anti-AIDS drugs....
Source: PhysOrg - Friday, 10 February
Related articles:
- Less than a week ago
- 2Vote! Smart highways to avoid traffic jams
PhysOrg - 4 days ago
- Older News
- 6Vote! Swiss scientists demonstrate mind-controlled robot
Yahoo Science News - Tuesday, 24 April
- 4Vote! Swiss scientists demonstrate mind controlled robot
- 2Vote! Venture capital investments fall 19 percent in 1Q
- 7Vote! Swiss solar plane to attempt 48-hour flight to Morocco
- 4Vote! Cancer drug forces HIV out of hiding
Futurity.org - Monday, 12 March
- 5Vote! Drug helps purge hidden HIV virus, study shows
e! Science News - Friday, 9 March
- 5Vote! Manager’s history sways investment choice
- 5Vote! In Swiss city, 'augmented reality' is out of this world
- 8Vote! Venture capital managers affect firms' success, study finds
- 7Vote! Old drug reveals new tricks
LabSpaces - Thursday, 1 March
- 8Vote! Colonialism in Africa helped launch the HIV epidemic a century ago
- 6Vote! Cable cos. shut down interactive ad venture
- 3Vote! Swiss pilot to undergo 3-day solar flight simulation
- 4Vote! EU approves skin cancer fighting drug: Roche
- 8Vote! Research aids nasal drug delivery
- 4Vote! Counterfeits of cancer drug Avastin found in U.S.
(Reuters)
- 9Vote! Swiss craft janitor satellites to grab space junk
- 6Vote! Swiss craft janitor satellites to grab space junk
(AP)
- 6Vote! Counterfeits of Roche cancer drug found in U.S.
(Reuters)
